Thierry Jahan, M.D. Discusses Clinical Trial Using CRS-207 Vaccine in Mesothelioma
UCSF Thoracic Oncology Program - - July 28, 2016
Former professor Thierry Jahan, M.D., discussed clinical data from the study, Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma, at the ESMO/IASLC European Congress on Lung Cancer in Geneva in April 2016. This is a Phase Ib trial of CRS-207 in malignant pleural mesothelioma (MPM). Dr. Jahan spoke at OncLive, the official Website for the Oncology Specialty Group:
Thierry M. Jahan, MD, a clinical professor in the Department of Medicine at the University of California San Francisco Helen Diller Family Comprehensive [...]